Tissue-resident CD8+ T cells drive age-associated chronic lung sequelae after viral pneumonia

Nick P Goplen1,2, Yue Wu3, Young Min Son1

  • 1Division of Pulmonary and Critical Medicine, Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Science Immunology
|November 7, 2020
PubMed

Insights

Aging impairs CD8+ T cells, causing chronic lung inflammation after viral pneumonia. Depleting these dysfunctional T cells resolves inflammation and fibrosis in older animals, highlighting age-related immune deficits.

Area of Science:

  • Immunology
  • Gerontology
  • Respiratory Medicine

Background:

  • Lower respiratory viral infections, including influenza and SARS-CoV-2, cause severe pneumonia in the elderly.
  • Aging is associated with altered immune responses and increased susceptibility to infections.

Purpose of the Study:

  • To investigate the role of CD8+ tissue-resident memory T cells (T_RM) in chronic lung pathology following viral pneumonia in aged individuals.
  • To understand the mechanisms underlying T_RM dysfunction and its contribution to persistent inflammation and fibrosis.

Main Methods:

  • Induction of influenza viral pneumonia in aged and young animal models.
  • Analysis of CD8+ T_RM cell accumulation, phenotype, and function in aged lungs.
  • Assessment of the impact of CD8+ T_RM cell depletion on lung inflammation and fibrosis.

Main Results:

  • Influenza viral pneumonia in aged hosts leads to nonresolving lung pathology and increased CD8+ T_RM cell accumulation.
  • Age-associated T_RM cells exhibit impaired TCR signaling and effector functions, linked to elevated TGF-β.
  • Depletion of CD8+ T_RM cells reduces chronic inflammation and fibrosis in aged animals.

Conclusions:

  • Age-associated malfunction of CD8+ T_RM cells exacerbates chronic lung inflammation and fibrosis post-viral pneumonia.
  • Targeting these dysfunctional T cells may offer therapeutic strategies for age-related respiratory complications.

Related Concept Videos

Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
3.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.0K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.4K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
993